Intai Technology Corp. AI Stock Analysis
Intai Technology Corp. (4163) AI Stock Analysis
Intai Technology Corp.
(TPEx:4163)
Moderate financials form the base while weak technical momentum limits upside; reasonable valuation offers partial support.
Intai Technology Corp. (4163) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- TWD 6.36B
- Dividend Yield
- 2.78%
- Average Volume (3M)
- 51.04K
- Price to Earnings (P/E)
- 20.7
- Beta (1Y)
- 0.25
- Revenue Growth
- 4.16%
- EPS Growth
- 40.82%
- Country
- TW
- Employees
- 460
- Sector
- General
- Sector Strength
- 55
- Industry
- Manufacturing - Tools & Accessories
Intai Technology Corp. Business Overview & Revenue Model
Company Description
INTAI Technology Corporation, established in 1988 and headquartered in Taichung, Taiwan, is a diversified manufacturer. The company specializes in providing a broad spectrum of products to various sectors, including automotive, aerospace, precision h...
Intai Technology Corp. Financial Statement Overview
Summary
Stable balance sheet and recent cash flow recovery are offset by margin compression and modest revenue trends, yielding a moderate financial score.
Income Statement
58NeutralBalance Sheet
72PositiveCash Flow
68Positive| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.49B | 2.41B | 2.38B | 2.44B | 2.41B | 1.97B |
| Gross Profit | 1.08B | 1.07B | 983.31M | 1.03B | 972.91M | 789.60M |
| EBITDA | 459.92M | 463.34M | 509.87M | 584.82M | 655.76M | 396.37M |
| Net Income | 299.47M | 249.60M | 259.89M | 340.58M | 422.33M | 228.44M |
Balance Sheet | ||||||
| Total Assets | 4.76B | 4.85B | 4.67B | 4.79B | 4.56B | 3.75B |
| Cash, Cash Equivalents and Short-Term Investments | 814.05M | 990.83M | 877.15M | 1.32B | 1.16B | 872.76M |
| Total Debt | 1.09B | 1.46B | 1.40B | 1.62B | 1.51B | 1.23B |
| Total Liabilities | 2.00B | 2.08B | 2.00B | 2.25B | 2.31B | 1.82B |
| Stockholders Equity | 2.70B | 2.71B | 2.61B | 2.47B | 2.25B | 1.93B |
Cash Flow | ||||||
| Free Cash Flow | 392.56M | 287.10M | 64.65M | 191.19M | 18.67M | -300.96M |
| Operating Cash Flow | 504.05M | 471.90M | 274.58M | 579.48M | 426.29M | 61.03M |
| Investing Cash Flow | -261.76M | -245.95M | -379.20M | -342.68M | -335.40M | -254.81M |
| Financing Cash Flow | -420.92M | -106.37M | -341.35M | -29.72M | 192.22M | 23.93M |
Intai Technology Corp. Peers Comparison
Overall Rating
TW:412668Neutral
TW:412968Neutral
TW:178863Neutral
TW:416760Neutral
TW:416360Neutral
TW:649933Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 68Neutral | TWD 5.39B | 12.54 | ― | 6.00% | 1.32% | 7.25% | |
| 68Neutral | TWD 7.01B | 12.73 | ― | 6.19% | 18.91% | 10.75% | |
| 63Neutral | TWD 5.57B | 14.19 | ― | 5.56% | 7.58% | 13.04% | |
| 60Neutral | TWD 6.30B | 7.86 | ― | 4.18% | -0.05% | 64.82% | |
| 60Neutral | TWD 6.41B | 20.66 | ― | 2.78% | 4.16% | 40.82% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| 33Underperform | TWD 7.33B | -16.44 | ― | ― | 69.62% | 59.41% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| TW:4163 | Intai Technology Corp. | 126.00 | 30.50 | 31.94% | |
| TW:1788 | Hi-Clearance Inc. | 126.00 | -4.42 | -3.39% | |
| TW:4126 | Pacific Hospital Supply Co., Ltd. | 75.00 | -8.51 | -10.19% | |
| TW:4129 | United Orthopedic Corporation | 72.70 | -43.31 | -37.33% | |
| TW:4167 | Savior Lifetec Corp. | 19.25 | 2.57 | 15.39% | |
| TW:6499 | Medeon Biodesign, Inc. | 73.80 | -22.70 | -23.52% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 09, 2026
